Crosstalk between Interleukin-1β and Type I Interferons Signaling in Autoinflammatory Diseases.
crosstalk
inflammation
interleukin-1β
type I interferons
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
08 05 2021
08 05 2021
Historique:
received:
28
03
2021
revised:
28
04
2021
accepted:
06
05
2021
entrez:
2
6
2021
pubmed:
3
6
2021
medline:
26
10
2021
Statut:
epublish
Résumé
Interleukin-1β (IL-1β) and type I interferons (IFNs) are major cytokines involved in autoinflammatory/autoimmune diseases. Separately, the overproduction of each of these cytokines is well described and constitutes the hallmark of inflammasomopathies and interferonopathies, respectively. While their interaction and the crosstalk between their downstream signaling pathways has been mostly investigated in the frame of infectious diseases, little information on their interconnection is still available in the context of autoinflammation promoted by sterile triggers. In this review, we will examine the respective roles of IL-1β and type I IFNs in autoinflammatory/rheumatic diseases and analyze their potential connections in the pathophysiology of some of these diseases, which could reveal novel therapeutic opportunities.
Identifiants
pubmed: 34066649
pii: cells10051134
doi: 10.3390/cells10051134
pmc: PMC8150590
pii:
doi:
Substances chimiques
IL1B protein, human
0
Interferon Type I
0
Interleukin-1beta
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Front Immunol. 2021 Feb 01;11:619257
pubmed: 33603750
Sultan Qaboos Univ Med J. 2015 May;15(2):e157-70
pubmed: 26052447
J Clin Invest. 2020 Sep 1;130(9):4561-4573
pubmed: 32716363
Int J Mol Sci. 2020 Dec 04;21(23):
pubmed: 33291536
Nat Commun. 2018 Jan 2;9(1):25
pubmed: 29295985
Cell Mol Life Sci. 2012 Oct;69(20):3395-418
pubmed: 22527721
J Exp Med. 2020 Sep 7;217(9):
pubmed: 32573694
Z Rheumatol. 2020 Dec;79(10):1040-1045
pubmed: 32804304
Arthritis Res Ther. 2021 Jan 16;23(1):29
pubmed: 33451338
Arthritis Rheumatol. 2017 Nov;69(11):2124-2135
pubmed: 28777892
Semin Immunol. 2019 Jun;43:101282
pubmed: 31771763
Cell Physiol Biochem. 2018;51(5):2377-2396
pubmed: 30537741
F1000Res. 2018 Mar 12;7:309
pubmed: 29568506
Nat Rev Immunol. 2020 Feb;20(2):95-112
pubmed: 31558839
Trends Mol Med. 2020 Nov;26(11):987-1002
pubmed: 32631717
Trends Genet. 2021 Jan;37(1):46-58
pubmed: 32977999
Ann Rheum Dis. 2019 Dec;78(12):1642-1652
pubmed: 31582377
J Cell Sci. 2017 Dec 1;130(23):3955-3963
pubmed: 29196474
J Neurosci Res. 2017 Jul;95(7):1360-1372
pubmed: 27862176
Mol Cell. 2019 May 16;74(4):801-815.e6
pubmed: 30952515
Immunity. 2011 Feb 25;34(2):213-23
pubmed: 21349431
Cytokine. 2015 Aug;74(2):237-46
pubmed: 25814341
Nat Rev Rheumatol. 2015 Aug;11(8):483-92
pubmed: 25963881
Front Immunol. 2018 May 04;9:983
pubmed: 29780394
Clin Exp Allergy. 2012 Dec;42(12):1756-64
pubmed: 23181791
Bioinformation. 2010 Oct 06;5(4):166-7
pubmed: 21364780
Drugs. 2007;67(15):2187-210
pubmed: 17927284
Autoimmun Rev. 2020 Jul;19(7):102567
pubmed: 32376392
Cell Mol Immunol. 2017 Jan;14(1):22-35
pubmed: 27264686
J Interferon Res. 1988 Aug;8(4):559-70
pubmed: 3262700
Mod Rheumatol. 2021 Jan;31(1):1-12
pubmed: 32814461
Immunity. 2006 Sep;25(3):383-92
pubmed: 16979570
Nat Rev Rheumatol. 2020 Apr;16(4):222-237
pubmed: 32107482
J Clin Immunol. 2019 Jul;39(5):476-485
pubmed: 31144250
J Clin Invest. 2021 Feb 1;131(3):
pubmed: 33529160
Curr Rheumatol Rep. 2020 Jun 16;22(7):32
pubmed: 32548765
Mol Cell. 2018 Sep 6;71(5):825-840.e6
pubmed: 30100266
Lancet. 1989 Jul 29;2(8657):244-7
pubmed: 2569055
Infect Dis Clin North Am. 2012 Dec;26(4):917-29
pubmed: 23083824
Theranostics. 2020 Jan 12;10(5):2158-2171
pubmed: 32104502
Int Immunol. 2017 Nov 1;29(9):393-400
pubmed: 28387826
Int J Mol Sci. 2021 Jan 26;22(3):
pubmed: 33530487
N Engl J Med. 2020 Jan 16;382(3):211-221
pubmed: 31851795
Clin Exp Rheumatol. 2021 Jan-Feb;39(1):227
pubmed: 32573428
Virulence. 2018;9(1):1669-1684
pubmed: 30403913
J Neurol. 2021 Jan 8;:
pubmed: 33416999
Int Immunol. 2009 Apr;21(4):317-37
pubmed: 19246554
J Allergy Clin Immunol. 2017 Aug;140(2):543-552.e5
pubmed: 28087229
mBio. 2018 Mar 20;9(2):
pubmed: 29559569
Mult Scler Relat Disord. 2020 Oct;45:102332
pubmed: 32645635
Immunity. 2019 Apr 16;50(4):907-923
pubmed: 30995506
Arthritis Res Ther. 2018 Feb 08;20(1):27
pubmed: 29422069
Pathogens. 2021 Jan 25;10(2):
pubmed: 33503864
Expert Opin Ther Targets. 2020 Jan;24(1):37-46
pubmed: 31899994
Curr Opin Immunol. 2017 Dec;49:96-102
pubmed: 29128691
Sci Adv. 2021 Jan 6;7(2):
pubmed: 33523973
Brain. 2020 May 1;143(5):1414-1430
pubmed: 32282893
J Leukoc Biol. 2008 Oct;84(4):932-9
pubmed: 18495785
JAMA. 2021 Feb 23;325(8):765-779
pubmed: 33620411
Front Immunol. 2018 Feb 19;9:269
pubmed: 29515581
Trends Mol Med. 2018 Apr;24(4):338-347
pubmed: 29519620
RMD Open. 2020 Jun;6(2):
pubmed: 32611650
Cytokine. 2017 Sep;97:1-13
pubmed: 28551592
Nat Immunol. 2020 Sep;21(9):1094-1106
pubmed: 32747814
J Neuroinflammation. 2021 Feb 21;18(1):54
pubmed: 33612100
Proc R Soc Lond B Biol Sci. 1957 Sep 12;147(927):258-67
pubmed: 13465720
J Immunol. 2017 Jun 15;198(12):4553-4560
pubmed: 28583987
J Exp Med. 2003 Mar 17;197(6):711-23
pubmed: 12642603
Sultan Qaboos Univ Med J. 2015 Feb;15(1):e9-e21
pubmed: 25685392